Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1969 1
1971 2
1972 2
1974 1
1975 2
1976 6
1977 1
1978 2
1979 4
1980 7
1981 9
1982 5
1983 4
1984 9
1985 10
1986 4
1987 6
1988 5
1989 9
1990 14
1991 13
1992 17
1993 14
1994 14
1995 19
1996 11
1997 11
1998 13
1999 12
2000 16
2001 16
2002 13
2003 5
2004 22
2005 20
2006 20
2007 27
2008 33
2009 30
2010 25
2011 33
2012 38
2013 41
2014 34
2015 26
2016 39
2017 64
2018 54
2019 69
2020 73
2021 65
2022 47
2023 44
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

968 results

Results by year

Filters applied: . Clear all
Page 1
Incidence and progression of diabetic retinopathy: a systematic review.
Sabanayagam C, Banu R, Chee ML, Lee R, Wang YX, Tan G, Jonas JB, Lamoureux EL, Cheng CY, Klein BEK, Mitchell P, Klein R, Cheung CMG, Wong TY. Sabanayagam C, et al. Lancet Diabetes Endocrinol. 2019 Feb;7(2):140-149. doi: 10.1016/S2213-8587(18)30128-1. Epub 2018 Jul 11. Lancet Diabetes Endocrinol. 2019. PMID: 30005958
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
Gross JG, Glassman AR, Liu D, Sun JK, Antoszyk AN, Baker CW, Bressler NM, Elman MJ, Ferris FL 3rd, Gardner TW, Jampol LM, Martin DF, Melia M, Stockdale CR, Beck RW; Diabetic Retinopathy Clinical Research Network. Gross JG, et al. JAMA Ophthalmol. 2018 Oct 1;136(10):1138-1148. doi: 10.1001/jamaophthalmol.2018.3255. JAMA Ophthalmol. 2018. PMID: 30043039 Free PMC article. Clinical Trial.
Propranolol for Proliferative Diabetic Retinopathy.
Hendrick AM, Lavine JA, Domalpally A, Kulkarni AD, Ip MS. Hendrick AM, et al. Ophthalmic Surg Lasers Imaging Retina. 2018 Jan 1;49(1):35-40. doi: 10.3928/23258160-20171215-05. Ophthalmic Surg Lasers Imaging Retina. 2018. PMID: 29304264
Long-term outcomes of vitrectomy for proliferative diabetic retinopathy.
Schreur V, Brouwers J, Van Huet RAC, Smeets S, Phan M, Hoyng CB, de Jong EK, Klevering BJ. Schreur V, et al. Acta Ophthalmol. 2021 Feb;99(1):83-89. doi: 10.1111/aos.14482. Epub 2020 Jul 9. Acta Ophthalmol. 2021. PMID: 32643273 Free PMC article.
METHODS: Cumulative incidences were calculated for low vision (<0.3), re-vitrectomy in the study eye and fellow eye vitrectomy. To identify potential prognostic factors that associate with these outcomes, we used multivariable Cox regression models. ...
METHODS: Cumulative incidences were calculated for low vision (<0.3), re-vitrectomy in the study eye and fellow eye vitrectomy. To identi …
Diabetic Nephropathy in Type 2 Diabetic Retinopathy Requiring Panretinal Photocoagulation.
Ha M, Choi SY, Kim M, Na JK, Park YH. Ha M, et al. Korean J Ophthalmol. 2019 Feb;33(1):46-53. doi: 10.3341/kjo.2018.0034. Korean J Ophthalmol. 2019. PMID: 30746911 Free PMC article.
PURPOSE: To investigate the risk factors of diabetic nephropathy in patients with diabetic retinopathy requiring panretinal photocoagulation (PRP) and the visual prognosis. METHODS: A retrospective review of electronic medical records was conducted at Seoul St. ...
PURPOSE: To investigate the risk factors of diabetic nephropathy in patients with diabetic retinopathy requiring panretinal photocoagulation …
968 results